Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
the rights to all research results etc. Inclusion and diversity are goals in the Faculty's strategy. The University of Oslo has a personnel policy objective of achieving a balanced gender composition
-
as Transnational Advocates (PROBONO)" Apply for this job See advertisement Job description Two positions as PhD Research Fellow (SKO 1017) are available in the research project PROBONO . The project is
-
Inngjerdingen at Department of Pharmacology, Institute of Clinical Medicine, University of Oslo. The position is funded through the Research Council of Norway (FRIPRO). The Inngjerdingen lab focuses on NK cells
-
rights to research results. Inclusion and diversity are goals in the Faculty's strategy. The University of Oslo has a personnel policy objective of achieving a balanced gender composition. Furthermore, we
-
31st August 2025 Languages English English English 2 PhD Research fellow positions within Responsible Innovation and Regional Development. Apply for this job See advertisement This is Western Norway
-
. The position is linked to the CannaStress project (Deciphering endocannabinoid stress buffering in humans: Mechanistic and clinical investigations) funded by the Research Council of Norway (FRIPRO). The
-
.” Additionally, the Faculty of Health and Social Sciences is co-responsible for the research area “Innovation in the Public Sector” within the cross-faculty PhD program Responsible Innovation and Regional
-
15th September 2025 Languages English English English Three Senior researchers in global governance and the politics of knowledge Senior Researcher Apply for this job See advertisement About NUPI
-
of Law, Digitizing Sexual Violence Apply for this job See advertisement Job description One PhD fellowship is available at the Department of Criminology and Sociology of Law to undertake research as part
-
of Oslo. The position is funded through the Research Council of Norway (FRIPRO). The Inngjerdingen lab focuses on NK cells, and how extracellular vesicles from NK cells can be exploited for cancer therapy